China has donated and exported more than 350 million doses of COVID-19 vaccine to solve the problem of uneven distribution of vaccines around the world.

CCTV News:Yesterday (June 6th), Ceng Yixin, deputy director of the National Health and Wellness Commission, was interviewed by a reporter from the General Station to introduce the international assistance, cooperation, research and development and production of vaccines in Covid-19. As of June 4th, China has donated and exported more than 350 million doses of COVID-19 vaccine.

China is actively engaged in international cooperation in the research, development, production and use of vaccines in Covid-19. Some vaccine research and development units have cooperated with relevant institutions in more than 20 countries, including the United Arab Emirates, Brazil, Uzbekistan, the Philippines and Pakistan, to carry out phase III clinical trials. Some vaccine research and development units are cooperating with foreign companies to develop nucleic acid vaccines. Some vaccine research and development units have received financial support from the Innovation Alliance for Epidemic Prevention, and are currently conducting phase II and III clinical trials abroad.

In terms of production, China’s vaccine production enterprises have cooperated with many developing countries to rapidly promote the large-scale production of vaccines. The stock solution produced by some enterprises has been shipped to Brazil, Indonesia, Egypt, United Arab Emirates, Pakistan, Malaysia and other countries, and overseas sub-packaging has been started.

On the supply side, China has taken the lead in promising to make vaccines a global public product, contributing to the accessibility and affordability of vaccines in developing countries. By June 4th, China had donated 357.01 million doses of vaccines to more than 80 countries and exported them to more than 40 countries. China’s inactivated vaccine, recombinant protein vaccine and adenovirus vector vaccine have been approved for marketing or emergency use in more than 90 countries and regions around the world. On May 7th and June 1st, WHO successively listed the inactivated vaccine of Sinopharm Zhongsheng Beijing Institute and Beijing Kexing Zhongxin Crown in the emergency use list, which proved the safety and effectiveness of vaccines in China, and also helped to solve the uneven distribution of vaccines in the world.